Finally, TXNIP overexpression or loss affects the normal metabolism and function of these cells which are associated with bone metabolism disorders (Figure 5). Although TXNIP has a limiting effect on OCs through indirect effects caused by intercellular paracrine signaling, this effect is limited and does not suggest that TXNIP is entirely beneficial in bone resorption. The gene discussed is TXNIP; the disease is metabolic bone disorder.